In this episode of Targeted Talks, Aaron Lisberg, MD, discusses results from the phase 3 TROPION-Lung01 study of datopotamab in advanced or metastatic non–small cell lung cancer.
Aaron Lisberg, MD
Articles by Aaron Lisberg, MD
Latest Updated Articles
Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer CarePublished: December 15th 2023 | Updated: